ACADIA Pharmaceuticals Inc (ACAD)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 230,794 | -73,379 | -223,596 | -170,439 | -286,586 |
| Revenue | US$ in thousands | 957,797 | 726,437 | 517,235 | 484,145 | 441,755 |
| Operating profit margin | 24.10% | -10.10% | -43.23% | -35.20% | -64.87% |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $230,794K ÷ $957,797K
= 24.10%
The operating profit margin of ACADIA Pharmaceuticals Inc has shown a significant improvement over the years. Starting at a negative margin of -64.87% in December 31, 2020, the company managed to reduce its operating losses gradually, reaching -35.20% by December 31, 2021. Subsequently, the trend continued with a further improvement to -43.23% by December 31, 2022.
A turning point was reached in December 31, 2023, when the company achieved a positive operating profit margin of 10.10%, indicating a shift towards profitability. This positive trend was further solidified by a notable increase in operating profit margin to 24.10% by December 31, 2024.
Overall, the data reflects a remarkable recovery and enhancement of ACADIA Pharmaceuticals Inc's operating profit margin, showcasing the company's efforts in improving operational efficiency and financial performance.
Peer comparison
Dec 31, 2024